ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals Inc

ORIC

Market Cap$920.42M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ORIC Pharmaceuticals IncORIC Pharmaceuticals Inc-5.8--60%--
$12.00

Target Price by Analysts

15.1% upsideORIC Pharmaceuticals Target Price DetailsTarget Price
$0.81

Current Fair Value

92.3% downside

Overvalued by 92.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$920.42 Million
Enterprise Value$871.09 Million
Dividend Yield$0 (0%)
Earnings per Share$-1.83
Beta1.48
Outstanding Shares71,040,580

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.77
PEG-28.83
Price to Sales-
Price to Book Ratio3.48
Enterprise Value to Revenue1634.31
Enterprise Value to EBIT-5.93
Enterprise Value to Net Income-7
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

Insider Trades

ESG Score

No data

About ORIC Pharmaceuticals Inc

CEO: Jacob Chacko